Matinas Biopharma (MTNB) Earnings (2013 - 2026)
Matinas Biopharma (MTNB) earnings from Mar 31, 2013 to Mar 31, 2026. The TTM Matinas Biopharma (MTNB) earnings is -$11M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Matinas Biopharma (MTNB) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -47.24% |
| 3 Years TTM | -19.76% |
| 5 Years TTM | -13.87% |
| 10 Years TTM | +1.88% |
| All Time TTM | +2.76% |
Annual Earnings change of Matinas Biopharma (MTNB)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$1.92M | -81.43% |
| 2025 | -$10M | -57.36% |
| 2024 | -$24M | +5.71% |
| 2023 | -$23M | +9.24% |
| 2022 | -$21M | -9.79% |
| 2021 | -$23M | +3.70% |
| 2020 | -$22M | +29.25% |
| 2019 | -$17M | +23.37% |
| 2018 | -$14M | -9.10% |
| 2017 | -$15M | +103.82% |
| 2016 | -$7.60M | -16.85% |
| 2015 | -$9.14M | -10.57% |
| 2014 | -$10M | +175.47% |
| 2013 | -$3.71M | N/A |
Comparison Matinas Biopharma (MTNB) five years earnings CAGR with competitors
Matinas Biopharma (MTNB) five years earnings CAGR is -13.85%.